2-bromopalmitate has been researched along with Innate Inflammatory Response in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 3 (75.00) | 2.80 |
Authors | Studies |
---|---|
Sun, KY; Xiong, W; Zhang, X; Zhou, YH; Zhu, Y; Zou, X | 1 |
Cheng, ML; Dong, ZB; Liu, L; Lu, H; Wang, BJ; Wang, YJ; Xie, M; Zhu, HL | 1 |
Cheng, M; Jiao, M; Wang, B; Xie, M; Yu, L; Zhu, H | 1 |
Eitnier, RA; Haines, RJ; Wang, CY; Wang, F; Wu, MH; Yang, CGY | 1 |
4 other study(ies) available for 2-bromopalmitate and Innate Inflammatory Response
Article | Year |
---|---|
Metformin alleviates inflammation through suppressing FASN-dependent palmitoylation of Akt.
Topics: 4-Butyrolactone; Animals; Cell Membrane; Colitis; Dextran Sulfate; Down-Regulation; Enzyme Activation; Fatty Acid Synthases; Inflammation; Intestinal Mucosa; Lipopolysaccharides; Lipoylation; Macrophages; Male; Metformin; Mice; Mice, Inbred C57BL; Palmitates; Phosphorylation; Proto-Oncogene Proteins c-akt; RAW 264.7 Cells; Signal Transduction; TOR Serine-Threonine Kinases; Transcription Factor RelA | 2021 |
2-Bromopalmitate decreases spinal inflammation and attenuates oxaliplatin-induced neuropathic pain via reducing Drp1-mediated mitochondrial dysfunction.
Topics: Animals; Dynamins; Inflammasomes; Inflammation; Mitochondria; Neuralgia; NLR Family, Pyrin Domain-Containing 3 Protein; Oxaliplatin; Rats; Rats, Sprague-Dawley | 2022 |
2-Bromopalmitate attenuates inflammatory pain by maintaining mitochondrial fission/fusion balance and function.
Topics: Animals; Anti-Inflammatory Agents; Astrocytes; bcl-2-Associated X Protein; Behavior, Animal; Cell Line, Tumor; Disease Models, Animal; Dynamins; Freund's Adjuvant; Glial Fibrillary Acidic Protein; GTP Phosphohydrolases; Humans; Inflammation; Interleukin-1beta; Matrix Metalloproteinases; Membrane Potential, Mitochondrial; Mitochondrial Dynamics; Oxidative Stress; Pain; Palmitates; Rats, Sprague-Dawley; Reactive Oxygen Species; Spinal Cord; Tumor Necrosis Factor-alpha | 2021 |
Targeting palmitoyl acyltransferase ZDHHC21 improves gut epithelial barrier dysfunction resulting from burn-induced systemic inflammation.
Topics: Acyltransferases; Animals; Burns; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Epithelial Cells; Genotype; Inflammation; Interferon-gamma; Intestinal Mucosa; Jejunum; Lipoylation; Male; Mice, Inbred C57BL; Mice, Knockout; Palmitates; Permeability; Phenotype; Time Factors; Tumor Necrosis Factor-alpha | 2017 |